Accuracy of rapid microcapillary direct antibiotic susceptibility testing for urine samples collected with bacteriostatic boric acid from patients with suspected urinary tract infection

  01 April 2026

This study evaluated a rapid microcapillary direct-from-urine (RMD) antibiotic susceptibility testing (AST) method for patients with suspected urinary tract infections (UTIs), including samples preserved with boric acid.

Key findings:

  • High accuracy: RMD AST showed ~97% concordance with standard reference methods.
  • Fast results: Average turnaround time was ~5.9 hours, significantly faster than conventional AST.
  • Robust performance: Agreement between samples with and without boric acid was ~99%, indicating that boric acid does not interfere with the test.

Conclusion:
RMD AST is a reliable and rapid method for determining antibiotic susceptibility directly from urine samples, even when boric acid is used for preservation. This approach can support faster clinical decision-making and improved antimicrobial stewardship without requiring additional sample processing.

Author(s): Sarah Helen Needs et al
Smart Innovations  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS

BD





AMR NEWS

Your Biweekly Source for Global AMR Insights!

Stay informed with the essential newsletter that brings together all the latest One Health news on antimicrobial resistance. Delivered straight to your inbox every two weeks, AMR NEWS provides a curated selection of international insights, key publications, and the latest updates in the fight against AMR.

Don’t miss out on staying ahead in the global AMR movement—subscribe now!

Subscribe
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!